Favorable Effects of Tacrolimus Monotherapy on Myasthenia Gravis Patients

Background and Purpose: Tacrolimus (TAC) has been proven to be a rapid-acting, steroid-sparing agent for myasthenia gravis (MG) therapy. However, evidence related to the effectiveness of TAC alone is rare. Therefore, this study was performed to investigate the effect of TAC monotherapy in MG patient...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Neurol
Autors principals: Fan, Zhirong, Li, Zunbo, Shen, Faxiu, Zhang, Xueping, Lei, Lin, Su, Shengyao, Lu, Yan, Di, Li, Wang, Min, Xu, Min, Da, Yuwei
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2020
Matèries:
Neurology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7652845/
https://ncbi.nlm.nih.gov/pubmed/33193063
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2020.594152
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars